CCR2
| CC chemokine receptor type 2 | ||
|---|---|---|
|
|
||
| according to PDB 1KAD | ||
| other names |
Monocyte chemoattractant protein 1 receptor, MCP-1-R |
|
| Properties of human protein | ||
| Mass / length primary structure | 374 amino acids , 41,915 Da | |
| Identifier | ||
| External IDs | ||
| Orthologue (human) | ||
| Entrez | 729230 | |
| Ensemble | ENSG00000121807 | |
| UniProt | P41597 | |
| Refseq (mRNA) | NM_001123041.2 | |
| Refseq (protein) | NP_001116513.2 | |
| PubMed search |
729230
|
|
CCR2 ( CC chemokine receptor type 2 ) is a surface protein from the group of chemokine receptors .
properties
CCR2 is expressed by monocytes and IL-12 -activated NK cells . It is the receptor for CCL2 , CCL7 and CCL13 as well as beta-defensin . After binding of CCL2 chemotaxis is initiated via the PI3K , the small G-protein Rac and the protuberance of the lamellipodia . CCR2 is glycosylated , phosphorylated and sulfated .
CCR2 is involved in the development of some neurological diseases, autoimmune diseases , metabolic syndromes and arteriosclerosis .
Web links
Individual evidence
- ↑ T. O'Connor, L. Borsig, M. Heikenwalder: CCL2-CCR2 Signaling in Disease Pathogenesis. In: Endocrine, metabolic & immune disorders drug targets. Volume 15, Number 2, 2015, pp. 105-118, PMID 25772168 .